Purchase Order HHSN268201700155A
- Not listed
- This is a $164,633.80 firm fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the provision of sequencing systems, reagents, and related services to support genomic sequencing and analysis research. Illumina, a manufacturer of genetic analysis instruments and reagents, has previously held prime contracts and subcontracts with various federal agencies...
- This is a $75,560 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a manufacturer of genetic and genomic analysis equipment and reagents. The contract is for the delivery of various Illumina sequencing systems, consumables, and related support services. There is no set-aside designation for this contract. Illumina has a history of supporting genomic sequencing and analysis for federal agencies like the NIH, Centers for...
- This is a $303,238.66 firm fixed price delivery order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the provision of various Illumina sequencing systems, reagents, and consumables to support genomic sequencing and analysis for research and diagnostic purposes. Illumina is the sole manufacturer of the specified sequencing platforms. This award is part of a larger Indefinite...
- This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $646,396.36 and no set-aside designation. Illumina, a manufacturer of sequencing and array-based genomic analysis solutions, will provide a range of sequencing systems, reagents, and services to support NHLBI's research and diagnostics needs. Illumina has a history of...
- This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The $113,164.34 order is for the provision of sequencing systems, consumables, and maintenance services to support the agency's research and diagnostic needs. Illumina has a history of providing similar products and services to federal agencies like the NIH, Centers for Disease Control, and Department of...
- This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $15,575 contract is for the delivery of Illumina's proprietary sequencing systems, reagents, and related products and services to support the Institute's genomic research and diagnostics activities. This award is not associated with any...
- This is a firm fixed price delivery order awarded by the Department of Health and Human Services' National Institutes of Health to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis solutions. The $129,148.82 contract provides Illumina sequencing systems, reagents, consumables, and associated services to support genomic research and diagnostics at the National Institute of Environmental Health Sciences. This award is not set-aside and is part of a larger Indefinite...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. The $57,950 contract is for the provision of Illumina's DNA sequencing systems, reagents, and related services to support genomic research and analysis. As the sole manufacturer of the sequencing instruments being used, Illumina has also received a related indefinite...
- This is a firm fixed price delivery order awarded to Illumina, Inc., a manufacturer of genetic and genomic analysis products, by the Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences. The contract, valued at $248,836.42, is for the provision of various Illumina sequencing systems, reagents, and consumables to support genomic sequencing and analysis research and diagnostics. Illumina has a history of providing similar...
- This is a firm fixed-price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $383,592.54 contract is for the provision of various Illumina sequencing systems, reagents, consumables, and related services to support genomic sequencing and analysis. The award is not set aside and was made on a sole-source basis, with Illumina identified as the sole manufacturer of the required sequencing...
This is a $230,639.31 firm fixed price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The contract provides for a comprehensive extended warranty renewal on Illumina's sequencing systems, which have been previously used to support genomic sequencing and analysis research and diagnostics work across federal agencies like the NIH, CDC, USDA, and VA. The contract does not have a set-aside designation. Illumina has also been awarded an Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery worth up to $3.3 million to provide sequencing reagents and controls in support of the Naval Medical Research Center's biological threat characterization efforts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Close Out | $0 | 9/6/23 | |
| P00001 | Other Administrative Action | 0$ | 4/5/22 | |
| Not listed | Not listed | $230.6k | 4/11/17 |